World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
78
Citations
27921
World Ranking
1729
National Ranking
850

Overview

Mark J. Mulligan is affiliated with New York University in the United States. Their research primarily focuses on Medicine, with a strong emphasis on Infectious Diseases, Immunology, and Epidemiology. This work also touches on related fields such as Molecular Biology and Animal Science and Zoology.

The scientist's research extensively covers topics connected to SARS-CoV-2 and COVID-19, including clinical research studies, detection and testing methods, vaccine coverage and hesitancy, as well as immunotherapy and immune responses. Additionally, their work includes investigations into animal virus infections and influenza virus research.

Recent notable publications by Mark J. Mulligan include:

  • Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults, 2020, Nature
  • Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates, 2020, New England Journal of Medicine
  • Homologous and Heterologous Covid-19 Booster Vaccinations, 2022, New England Journal of Medicine
  • The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates, 2021, Science Translational Medicine
  • Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials, 2021, Nature Communications

Mark J. Mulligan frequently collaborates with fellow researchers such as Marie I. Samanovic, Nadine Rouphael, Ramin S. Herati, Evan J. Anderson, and Lilin Lai.

The scientist's work has appeared in several publication venues, with multiple contributions to bioRxiv (Cold Spring Harbor Laboratory), Vaccines, Vaccine, Open Forum Infectious Diseases, and The Journal of Infectious Diseases.

Best Publications

  • Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.

    Edward E. Walsh;Robert W. Frenck;Ann R. Falsey;Ann R. Falsey;Nicholas Kitchin

  • Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults.

    Mark J. Mulligan;Kirsten E. Lyke;Nicholas Kitchin;Judith Absalon

  • Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans

    Troy D Querec;Rama Akondy;Eva K Lee;Weiping Cao

  • Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection

    Jens Wrammert;Dimitrios G. Koutsonanos;Gui-Mei Li;Srilatha Edupuganti

  • Homologous and Heterologous Covid-19 Booster Vaccinations

    Unknown

  • Molecular signatures of antibody responses derived from a systems biology study of five human vaccines

    Shuzhao Li;Nadine Rouphael;Sai Duraisingham;Sandra Romero-Steiner

  • Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine

    Scott M. Hammer;Magdalena E. Sobieszczyk;Holly Janes;Shelly T. Karuna

  • Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines.

    Joseph D. Miller;Robbert G. van der Most;Rama S. Akondy;John T. Glidewell

  • Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus

    Lalita Priyamvada;Kendra M. Quicke;William H. Hudson;Nattawat Onlamoon

  • Origin and differentiation of human memory CD8 T cells after vaccination

    Rama Akondy;Mark Fitch;Srilatha Edupuganti;Shu Yang

  • The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial

    Nadine G Rouphael;Michele Paine;Regina Mosley;Sebastien Henry

  • Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells

    Gui-Mei Li;Christopher Chiu;Jens Wrammert;Megan McCausland

  • Magnitude of Functional CD8+ T-Cell Responses to the Gag Protein of Human Immunodeficiency Virus Type 1 Correlates Inversely with Viral Load in Plasma

    Bradley H. Edwards;Anju Bansal;Steffanie Sabbaj;Janna Bakari

  • The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates.

    Bryan E. Jones;Patricia L. Brown-Augsburger;Kizzmekia S. Corbett;Kathryn Westendorf

  • Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection

    Unknown

  • The Yellow Fever Virus Vaccine Induces a Broad and Polyfunctional Human Memory CD8+ T Cell Response

    Rama S. Akondy;Nathan D. Monson;Joseph D. Miller;Srilatha Edupuganti

  • Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine.

    Ann R Falsey;Magdalena E Sobieszczyk;Ian Hirsch;Stephanie Sproule

  • Systems Analysis of Immunity to Influenza Vaccination across Multiple Years and in Diverse Populations Reveals Shared Molecular Signatures

    Helder I. Nakaya;Thomas Hagan;Sai S. Duraisingham;Eva K. Lee

  • Protection against vaginal SIV transmission with microencapsulated vaccine

    Preston A. Marx;Richard W. Compans;Agegnehu Gettie;Jay K. Staas

  • Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials

    Martin R Gaudinski;Katherine V Houser;Kaitlyn M Morabito;Zonghui Hu

  • Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials.

    Cathrine Axfors;Cathrine Axfors;Andreas M. Schmitt;Andreas M. Schmitt;Perrine Janiaud;Janneke van’t Hooft;Janneke van’t Hooft

  • A Canarypox Vaccine Expressing Multiple Human Immunodeficiency Virus Type 1 Genes Given Alone or with Rgp120 Elicits Broad and Durable CD8+ Cytotoxic T Lymphocyte Responses in Seronegative Volunteers

    Thomas G. Evans;Michael C. Keefer;Kent J. Weinhold;Mark Wolff

Frequent Co-Authors

Nadine Rouphael
Nadine Rouphael Emory University
Rafi Ahmed
Rafi Ahmed Emory University
Paul A. Goepfert
Paul A. Goepfert University of Alabama at Birmingham
M. Juliana McElrath
M. Juliana McElrath University of Washington
Sharon E. Frey
Sharon E. Frey Saint Louis University
Bali Pulendran
Bali Pulendran Stanford University
Michael C. Keefer
Michael C. Keefer University of Rochester
Barney S. Graham
Barney S. Graham Morehouse School of Medicine
Robert B. Belshe
Robert B. Belshe Saint Louis University
Wendy A. Keitel
Wendy A. Keitel Baylor College of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related fields such as nursing can open diverse career opportunities. Many professionals consider advanced nursing roles specializing in mental health and psychiatric care, which often require strong clinical skills and advanced degrees.

One can pursue an easiest np program to start building foundational knowledge before moving into specialized areas like psychiatric mental health nurse practitioner roles. These programs balance accessibility with quality education, making them a popular choice for busy students.

When looking for specialized training, online options for online pmhnp programs with clinical placement are invaluable. They provide hands-on clinical experience, essential for certification and real-world practice, even in a virtual learning environment.

Cost is another critical factor; finding the cheapest psych np programs online can make advanced education more accessible without sacrificing quality. Scholarships and flexible payment plans often accompany these affordable programs.

Finally, understanding the financial outlook is important. According to recent data on doctorate in nursing salary, earning potential varies by location but generally reflects rewarding compensation for advanced practitioners.

Best Scientists Citing Mark J. Mulligan

Trending Scientists

Recently Published Articles